Priscilla Howard, who has metastatic breast cancer, has been taking Avastin for a little more than two years and has seen a remarkable difference in the progression of her disease, she told a panel of experts at the U.S. Food and Drug Administration during the first day of the two-day hearing.
day hearing will be held that will pit the drug evaluation centre of FDA against Genentech. On the first day of hearing, Priscilla Howard, who is suffering from metastatic breast cancer, told a panel of some experts from FDA that the use of Avastin has remarkably affected the progression of disease.
"Despite the potential side effects from Avastin, metastatic breast cancer has only one death," Priscilla Howard, who said Avastin had controlled her cancer for 32 months, told the committee presiding over the hearing. "I want every available weapon in my arsenal as I fight this devastating diseas